MarketBeat Instant News Alerts 2 hours agoFY2025 Earnings Estimate for MRK Issued By Cantor FitzgeraldMarketBeatMerck & Co., Inc. (NYSE:MRK - Free Report) - Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for shares of Merck & Co., Inc. in a report released on Thursday, October 9th. Cantor Fitzgerald analyst C. Gould now expects that the company will earn $8.94 per share forNYSE:MRKRead FY2025 Earnings Estimate for MRK Issued By Cantor Fitzgerald2 hours agoLifecore Biomedical's (LFCR) Sell (D) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d)" rating on shares of Lifecore Biomedical in a report on Wednesday.NASDAQ:LFCRRead Lifecore Biomedical's (LFCR) Sell (D) Rating Reaffirmed at Weiss Ratings2 hours agoLife360's (LIF) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c)" rating on shares of Life360 in a research note on Wednesday.NASDAQ:LIFRead Life360's (LIF) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoLiberty Media Corporation - Liberty Live Series A's (LLYVA) Sell (D) Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of Liberty Media Corporation - Liberty Live Series A in a research note on Wednesday.NASDAQ:LLYVARead Liberty Media Corporation - Liberty Live Series A's (LLYVA) Sell (D) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D) Rating for Liberty Media Corporation - Liberty Live Series C (NASDAQ:LLYVK)MarketBeatWeiss Ratings reaffirmed a "sell (d)" rating on shares of Liberty Media Corporation - Liberty Live Series C in a report on Wednesday.NASDAQ:LLYVKRead Weiss Ratings Reiterates Sell (D) Rating for Liberty Media Corporation - Liberty Live Series C (NASDAQ:LLYVK)2 hours agoLiberty Global's (LILAK) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Liberty Global in a research note on Wednesday.NASDAQ:LILAKRead Liberty Global's (LILAK) Sell (D-) Rating Reaffirmed at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks Research2Quantum Computing Stocks To Keep An Eye On - October 7th3Zacks Research Issues Pessimistic Outlook for NIO Earnings4IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened5AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital6Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?7DraftKings (NASDAQ:DKNG) Shares Down 4.7% Following Analyst Downgrade8Kratos Defense & Security Solutions (NASDAQ:KTOS) Stock Price Down 6.6% After Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoLiberty Latin America's (LILA) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:LILARead Liberty Latin America's (LILA) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoLi Auto's (LI) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:LIRead Li Auto's (LI) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoLGI Homes' (LGIH) Sell (D+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:LGIHRead LGI Homes' (LGIH) Sell (D+) Rating Reaffirmed at Weiss Ratings2 hours agoLexinFintech (NASDAQ:LX) Receives Hold (C+) Rating from Weiss RatingsMarketBeatNASDAQ:LXRead LexinFintech (NASDAQ:LX) Receives Hold (C+) Rating from Weiss Ratings2 hours agoLexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:LXRXRead Lexicon Pharmaceuticals' (LXRX) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoLexeo Therapeutics (NASDAQ:LXEO) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:LXEORead Lexeo Therapeutics (NASDAQ:LXEO) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoLesaka Technologies (NASDAQ:LSAK) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:LSAKRead Lesaka Technologies (NASDAQ:LSAK) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoWedbush Issues Positive Forecast for TSM EarningsMarketBeatNYSE:TSMRead Wedbush Issues Positive Forecast for TSM Earnings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for LENZ Therapeutics (NASDAQ:LENZ)MarketBeatNASDAQ:LENZRead Weiss Ratings Reiterates Sell (D-) Rating for LENZ Therapeutics (NASDAQ:LENZ)2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for LENSAR (NASDAQ:LNSR)MarketBeatNASDAQ:LNSRRead Weiss Ratings Reiterates Sell (D-) Rating for LENSAR (NASDAQ:LNSR)2 hours agoLeMaitre Vascular (NASDAQ:LMAT) Earns Buy (B-) Rating from Weiss RatingsMarketBeatNASDAQ:LMATRead LeMaitre Vascular (NASDAQ:LMAT) Earns Buy (B-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Leishen Energy (NASDAQ:LSE)MarketBeatNASDAQ:LSERead Weiss Ratings Reaffirms "Sell (D-)" Rating for Leishen Energy (NASDAQ:LSE)2 hours agoLegend Biotech (NASDAQ:LEGN) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:LEGNRead Legend Biotech (NASDAQ:LEGN) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoLegalZoom.com (NASDAQ:LZ) Given Hold (C-) Rating at Weiss RatingsMarketBeatNASDAQ:LZRead LegalZoom.com (NASDAQ:LZ) Given Hold (C-) Rating at Weiss Ratings2 hours agoLegacy Housing's (LEGH) Buy (B-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:LEGHRead Legacy Housing's (LEGH) Buy (B-) Rating Reiterated at Weiss Ratings2 hours agoLavoro (NASDAQ:LVRO) Given Sell (E+) Rating at Weiss RatingsMarketBeatNASDAQ:LVRORead Lavoro (NASDAQ:LVRO) Given Sell (E+) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C-) Rating for Lattice Semiconductor (NASDAQ:LSCC)MarketBeatNASDAQ:LSCCRead Weiss Ratings Reaffirms Hold (C-) Rating for Lattice Semiconductor (NASDAQ:LSCC)2 hours agoWeiss Ratings Reiterates Hold (C) Rating for Lakeland Financial (NASDAQ:LKFN)MarketBeatNASDAQ:LKFNRead Weiss Ratings Reiterates Hold (C) Rating for Lakeland Financial (NASDAQ:LKFN)2 hours agoLarimar Therapeutics (NASDAQ:LRMR) Given Sell (D-) Rating at Weiss RatingsMarketBeatNASDAQ:LRMRRead Larimar Therapeutics (NASDAQ:LRMR) Given Sell (D-) Rating at Weiss Ratings2 hours agoLanzaTech Global (NASDAQ:LNZA) Given Sell (E+) Rating at Weiss RatingsMarketBeatNASDAQ:LNZARead LanzaTech Global (NASDAQ:LNZA) Given Sell (E+) Rating at Weiss Ratings2 hours agoLantronix's (LTRX) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:LTRXRead Lantronix's (LTRX) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoLantheus (NASDAQ:LNTH) Given Hold (C-) Rating at Weiss RatingsMarketBeatNASDAQ:LNTHRead Lantheus (NASDAQ:LNTH) Given Hold (C-) Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D+)" Rating for Landstar System (NASDAQ:LSTR)MarketBeatNASDAQ:LSTRRead Weiss Ratings Reiterates "Sell (D+)" Rating for Landstar System (NASDAQ:LSTR)2 hours agoLands' End's (LE) Hold (C-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:LERead Lands' End's (LE) Hold (C-) Rating Reiterated at Weiss Ratings Featured Articles and OffersD-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks ResearchBy MarketBeat | October 8, 2025What if your job didn’t matter — and neither did China’s chip ban?From Timothy Sykes (Ad)3 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Quantum Computing Stocks To Keep An Eye On - October 7thBy MarketBeat | October 9, 2025Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025The $7 company helping Nvidia build the world’s first trillion-dollar robot …From Weiss Ratings (Ad)When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025Why These 3 Tech Stocks Deserve Your Attention in Q4By Thomas Hughes | October 3, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
